BioCryst Pharma (BCRX) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BE
8. FIX
9. PNFP
10. NDAQ

Go back to BioCryst Pharma (BCRX) Misses Q3 EPS by 3c

BioCryst Reports Third Quarter 2018 Financial Results

November 6, 2018 7:00 AM EST

APeX-2 study enrollment completed, results on-track for Q2 2019

RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced financial results for the third quarter ended September 30, 2018.

With enrollment in APeX-2 complete, and the successful results from ZENITH-1, we are excited with the momentum that is... More